CHLOROQUINE DIPHOSPHATE CRYSTALLINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS
MEVINOLIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
4'-HYDROXYWARFARIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
CARBOXYTOLBUTAMIDE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
CYTOCHROME P450 CYP2C9 ISOZYME
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, OXIDATIVE PATHWAY
UDP-GLYCOSYLTRANSFERASE 1A6 ISOZYME
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, CONJUGATE PATHWAY
MITHRAMYCIN A FROM STREPTOMYCES*PLICATUS APPROX. 96
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS
MORPHINE-3,6-DIGLUCURONIDE TETRAHYDRATE, DEA SCHEDULE II
Morphine-3,6-diglucuronide tetrahydrate, To be determined
MDR1 MEMBRANE PREPARATION
MDR1 human, membrane preparation, for ATPase, Sf9 cells
(R)-(-)-NIRVANOL
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES